Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Johnson & Johnson Reports Decline in Short Interest, Declares Dividend

January 05, 2025
Johnson & Johnson, a multinational pharmaceutical company, recently declared its quarterly dividend and reported a decline in short interest. The company's dividend reflects its commitment to providing returns to its shareholders. Additionally, the decline in short interest indicates positive sentiments and confidence in the company's performance. This news suggests that Johnson & Johnson continues to maintain a strong position in the market. For more information and professional forecasts on the movement of Johnson & Johnson stocks, it is recommended to consult Stocks Prognosis.

Find out how the JOHNSON & JOHNSON rate is expected to change

Get Forecast for JNJ

Investor opinions & comments:

Great news! I am glad to see Johnson & Johnson's commitment to providing returns to its shareholders through its quarterly dividend. This reflects the company's stability and strong market position
— from SophiaHarris at 01-08-2025 10:03
I'm skeptical about the decline in short interest. It could just be a temporary trend and may not necessarily reflect the overall market sentiment towards Johnson & Johnson. I would like to see more data before drawing any conclusions
— from IsaacPerry at 01-07-2025 18:10
I am excited to see Johnson & Johnson's positive news. The company's dividend and decline in short interest demonstrate its financial stability and market resilience. It is definitely a good sign for investors
— from SadieColeman at 01-07-2025 16:46
I remain skeptical about the company's strong position in the market. Decline in short interest alone may not be enough evidence to support this claim. I would like to see more financial data and analysis before forming an opinion
— from ProfitPat at 01-07-2025 03:54
Great news! Johnson & Johnson's quarterly dividend and decline in short interest further reinforce the company's reputation as a reliable and profitable investment. I have confidence in their long-term growth
— from CapitalCathy at 01-06-2025 11:28
I'm interested to know more about the decline in short interest. It is a positive sign and shows that investors have confidence in Johnson & Johnson's performance. It would be interesting to see how this trend continues
— from VictoriaKelley at 01-06-2025 05:14
Johnson & Johnson's commitment to its shareholders is commendable. The decline in short interest shows that investors believe in the company's strong performance. I'm optimistic about its future
— from AnthonyBennett at 01-06-2025 03:09
As a shareholder, I am pleased to see Johnson & Johnson's commitment to providing returns. It is reassuring to know that the company is in a strong position and continues to perform well in the market
— from ThomasHawkins at 01-05-2025 23:46
I'm not so sure about the positive sentiments surrounding Johnson & Johnson's performance. There could be other factors influencing the decline in short interest, and it may not necessarily indicate confidence in the company's future prospects
— from RileyHughes at 01-05-2025 04:30
If you want to leave a comment, then you need Login or Register





Other news for JNJ

JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....

JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....



Related news

CABOFebruary 7, 2025Cable One Inc. Announces Quarterly Dividend of 2.95  ~1 min.

Cable One Inc. (NYSE:CABO) has announced its plans to distribute a quarterly dividend of $2.95 per share to its shareholders....

MMCMarch 19, 2025Marsh McLennan Declares Quarterly Cash Dividend, Recommends Consultation with Stocks Prognosis  ~1 min.

Marsh McLennan Companies, Inc. (NYSE:MMC) has declared a quarterly cash dividend of $0.815 per share. The dividend is payable on May 15 to shareholders of record as of April 3....

AWKDecember 11, 2024American Water Works Declares 0.765 Quarterly Dividend  ~1 min.

American Water Works Company, Inc. (AWK) has announced the declaration of its quarterly dividend of $0.765 per share....

TGTMarch 18, 2025Target Corporation Declares Regular Quarterly Dividend  ~1 min.

Target Corporation, a leading retail company, has announced the declaration of its regular quarterly dividend....

AEPJanuary 28, 2025American Electric Power Company Extends Dividend Streak with 0.93 Quarterly Payment  ~1 min.

American Electric Power Company, Inc. (NASDAQ: AEP) announced today that it will continue its impressive track record of dividend payments with a quarterly dividend of 0.93 per share....